The spinal cord injury (SCI) research community has experienced great advances in discovery research, technology development, and promising clinical interventions in the past decade. To build upon these advances and maximize the benefit to persons with SCI, the National Institutes of Health (NIH) hosted a conference February 12–13, 2019 titled “SCI 2020: Launching a Decade of Disruption in Spinal Cord Injury Research.” The purpose of the conference was to bring together a broad range of stakeholders, including researchers, clinicians and healthcare professionals, persons with SCI, industry partners, regulators, and funding agency representatives to break down existing communication silos. Invited speakers were asked to summarize the state of the science, assess areas of technological and community readiness, and build collaborations that could change the trajectory of research and clinical options for people with SCI. In this report, we summarize the state of the science in each of five key domains and identify the gaps in the scientific literature that need to be addressed to move the field forward.
Get full access to this article
View all access options for this article.
References
1.
AllenA.R. (1914). Remarks on the histopathological changes in the spinal cord due to impact—an experimental study. J. Nerv. Ment. Dis. 41, 141–147.
2.
BadhiwalaJ.H., AhujaC.S., and FehlingsM.G. (2018). Time is spine: a review of translational advances in spinal cord injury. J. Neurosurg. Spine, 30, 1–18.
3.
KwonB.K., TetzlaffW., GrauerJ.N., BeinerJ., and VaccaroA.R. (2004). Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 4, 451–464.
4.
TatorC.H., and FehlingsM.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15–26.
5.
SimardJ.M., TsymbalyukO., IvanovA., IvanovaS., BhattaS., GengZ., WooS.K., and GerzanichV. (2007). Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J. Clin. Invest. 117, 2105–2113.
6.
DokalisN., and PrinzM. (2019). Resolution of neuroinflammation: mechanisms and potential therapeutic option. Semin. Immunopathol. 41, 699–709.
7.
WuJ., and LipinskiM.M. (2019). Autophagy in neurotrauma: good, bad, or dysregulated. Cells, 8, 693.
8.
CorpsK.N., RothT.L., and McGavernD.B. (2015). Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 72, 355–362.
ZhaoZ., NelsonA.R., BetsholtzC., and ZlokovicB.V. (2015). Establishment and dysfunction of the blood-brain barrier. Cell, 163, 1064–1078.
11.
AarabiB., SimardJ.M., KuferaJ.A., AlexanderM., ZacherlK.M., MirvisS.E., ShanmuganathanK., SchwartzbauerG., MaulucciC.M., SlavinJ., AliK., MassettiJ., and EisenbergH.M. (2012). Intramedullary lesion expansion on magnetic resonance imaging in patients with motor complete cervical spinal cord injury. J. Neurosurg. Spine, 17, 243–250.
12.
BilgenM., AbbeR., LiuS.J., and NarayanaP.A. (2000). Spatial and temporal evolution of hemorrhage in the hyperacute phase of experimental spinal cord injury: in vivo magnetic resonance imaging. Magn. Reson. Med. 43, 594–600.
13.
DavidG., MohammadiS., MartinA.R., Cohen-AdadJ., WeiskopfN., ThompsonA., and FreundP. (2019). Traumatic and nontraumatic spinal cord injury: pathological insights from neuroimaging. Nat. Rev. Neurol. 15, 718–731.
14.
KawataK., MorimotoT., OhashiT., TsujimotoS., HoshidaT., TsunodaS., and SakakiT. (1993). [Experimental study of acute spinal cord injury: a histopathological study]. [Article in Japanese]. No Shinkei Geka, 21, 45–51.
15.
TatorC.H., and KoyanagiI. (1997). Vascular mechanisms in the pathophysiology of human spinal cord injury. J. Neurosurg. 86, 483–492.
16.
SimardJ.M., PopovichP.G., TsymbalyukO., CaridiJ., GullapalliR.P., KilbourneM.J., and GerzanichV. (2013). MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury. Spinal Cord, 51, 823–827.
17.
SimardJ.M., PopovichP.G., TsymbalyukO., and GerzanichV. (2012). Spinal cord injury with unilateral versus bilateral primary hemorrhage—effects of glibenclamide. Exp. Neurol. 233, 829–835.
18.
SimardJ.M., WooS.K., NorenbergM.D., TosunC., ChenZ., IvanovaS., TsymbalyukO., BryanJ., LandsmanD., and GerzanichV. (2010). Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma. Sci. Transl. Med. 2, 28ra29.
19.
MinnemaA.J., MehtaA., BolingW.W., SchwabJ., SimardJ.M., and FarhadiH.F. (2019). SCING-Spinal Cord Injury Neuroprotection with glyburide: a pilot, open-label, multicentre, prospective evaluation of oral glyburide in patients with acute traumatic spinal cord injury in the USA. BMJ Open, 9, e031329.
20.
SeahH.M., BurneyM., PhanM., ShellD., WuJ., ZhouK., BrooksO., CoultonB., MaingardJ., TangJ., YazdabadiG., TahayoriB., BarrasC., KokH.K., ChandraR., ThijsV., BrooksD.M., and AsadiH. (2019). CODE STROKE ALERT—concept and development of a novel open-source platform to streamline acute stroke management. Front. Neurol. 10, 725.
21.
LamC., ChenP.L., KangJ.H., ChengK.F., ChenR.J., and HungK.S. (2017). Risk factors for 14-day rehospitalization following trauma with new traumatic spinal cord injury diagnosis: a 10-year nationwide study in Taiwan. PLoS One, 12, e0184253.
22.
FehlingsM.G., VaccaroA., WilsonJ.R., SinghA., D, W.C., HarropJ.S., AarabiB., ShaffreyC., DvorakM., FisherC., ArnoldP., MassicotteE.M., LewisS., and RampersaudR. (2012). Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS One, 7, e32037.
23.
ErnstA.A. and FishS. (2005). Exception from informed consent: viewpoint of institutional review boards—balancing risks to subjects, community consultation, and future directions. Acad. Emerg. Med. 12, 1050–1055.
24.
TishermanS.A. (2018). Defining “Community”. and “Consultation” for Emergency Research that Requires an Exception from Informed Consent. AMA J. Ethics, 20, 467–474.
25.
EvaniewN., Belley-CoteE.P., FallahN., NoonanV.K., RiversC.S., and DvorakM.F. (2016). Methylprednisolone for the treatment of patients with acute spinal cord injuries: a systematic review and meta-analysis. J. Neurotrauma, 33, 468–481.
26.
OnkenL.S., CarrollK.M., ShohamV., CuthbertB.N., and RiddleM. (2014). Reenvisioning clinical science: unifying the discipline to improve the public health. Clin. Psychol. Sci. 2, 22–34.
27.
RaineteauO., and SchwabM.E. (2001). Plasticity of motor systems after incomplete spinal cord injury. Nat. Rev. Neurosci. 2, 263–273.
O'SheaT.M., BurdaJ.E., and SofroniewM.V. (2017). Cell biology of spinal cord injury and repair. J. Clin. Invest. 127, 3259–3270.
30.
MayrW., KrennM., and DimitrijevicM.R. (2016). Motor control of human spinal cord disconnected from the brain and under external movement. Adv. Exp. Med. Biol. 957, 159–171.
31.
ChenB., LiY., YuB., ZhangZ., BrommerB., WilliamsP.R., LiuY., HegartyS.V., ZhouS., ZhuJ., GuoH., LuY., ZhangY., GuX., and HeZ. (2018). Reactivation of dormant relay pathways in injured spinal cord by KCC2 manipulations. Cell, 174, 1599.
32.
BoulenguezP., LiabeufS., BosR., BrasH., Jean-XavierC., BrocardC., StilA., DarbonP., CattaertD., DelpireE., MarsalaM., and VinayL. (2010). Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury. Nat. Med. 16, 302–307.
HeZ., and JinY. (2016). Intrinsic control of axon regeneration. Neuron, 90, 437–451.
37.
AssinckP., DuncanG.J., HiltonB.J., PlemelJ.R., and TetzlaffW. (2017). Cell transplantation therapy for spinal cord injury. Nat. Neurosci. 20, 637–647.
38.
YangB., ZhangF., ChengF., YingL., WangC., ShiK., WangJ., XiaK., GongZ., HuangX., YuC., LiF., LiangC., and ChenQ. (2020). Strategies and prospects of effective neural circuits reconstruction after spinal cord injury. Cell Death Dis. 11, 439.
39.
DulinJ.N., AdlerA.F., KumamaruH., PoplawskiG.H.D., Lee-KubliC., StroblH., GibbsD., KadoyaK., FawcettJ.W., LuP., and TuszynskiM.H. (2018). Injured adult motor and sensory axons regenerate into appropriate organotypic domains of neural progenitor grafts. Nat. Commun. 9, 84.
40.
North American Spinal Cord Injury Consortium. (2019). NASCIC Survey Results 2019. North American Spinal Cord Injury Consortium: Niagara Falls,NY.
41.
IrelandN. (2019). ‘This is not a magic wand’: spinal stimulation used on Humboldt Bronco promising but in early research stages. CBC Radio-Canada. https://www.cbc.ca/news/health/epidural-stimulation-spinal-injury-humboldt-broncos-1.5353221 (Last accessd January 4, 2021).
42.
NIH Office of AIDSResearch. (2020). NIH HIV ResearchBudget. Page last reviewedDecember , 2020. www.oar.nih.gov/hiv-policy-and-research/budget (Last accessed January4, 2021).
43.
RodgerA.J., CambianoV., BruunT., VernazzaP., CollinsS., DegenO., CorbelliG.M., EstradaV., GerettiA.M., BeloukasA., RabenD., CollP., AntinoriA., NwokoloN., RiegerA., PrinsJ.M., BlaxhultA., WeberR., Van EedenA., BrockmeyerN.H., ClarkeA., Del Romero GuerreroJ., RaffiF., BognerJ.R., WandelerG., GerstoftJ., GutierrezF., BrinkmanK., KitchenM., OstergaardL., LeonA., RistolaM., JessenH., StellbrinkH.J., PhillipsA.N., and LundgrenJ.; PARTNER StudyGroup. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet, 393, 2428–2438.
44.
JamesN.D., McMahonS.B., Field-FoteE.C., and BradburyE.J. (2018). Neuromodulation in the restoration of function after spinal cord injury. Lancet Neurol. 17, 905–917.
45.
Garcia-AliasG., BarkhuysenS., BuckleM., and FawcettJ.W. (2009). Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat. Neurosci. 12, 1145–1151.
46.
IshikawaY., ImagamaS., OhgomoriT., IshiguroN., and KadomatsuK. (2015). A combination of keratan sulfate digestion and rehabilitation promotes anatomical plasticity after rat spinal cord injury. Neurosci. Lett. 593, 13–18.
47.
ShinozakiM., IwanamiA., FujiyoshiK., TashiroS., KitamuraK., ShibataS., FujitaH., NakamuraM., and OkanoH. (2016). Combined treatment with chondroitinase ABC and treadmill rehabilitation for chronic severe spinal cord injury in adult rats. Neurosci. Res. 113, 37–47.
48.
Torres-EspinA., ForeroJ., FenrichK.K., Lucas-OsmaA.M., KrajacicA., SchmidtE., VavrekR., RaposoP., BennettD.J., PopovichP.G., and FouadK. (2018). Eliciting inflammation enables successful rehabilitative training in chronic spinal cord injury. Brain, 141, 1946–1962.
49.
Field-FoteE.C. (2015). Exciting recovery: augmenting practice with stimulation to optimize outcomes after spinal cord injury. Prog. Brain Res. 218, 103–126.
50.
Gomes-OsmanJ., CortesM., GuestJ., and Pascual-LeoneA. (2016). A systematic review of experimental strategies aimed at improving motor function after acute and chronic spinal cord injury. J. Neurotrauma, 33, 425–438.
51.
MooreC.G., CarterR.E., NietertP.J., and StewartP.W. (2011). Recommendations for planning pilot studies in clinical and translational research. Clin. Transl. Sci. 4, 332–337.
52.
Gomes-OsmanJ., and Field-FoteE.C. (2015). Cortical vs. afferent stimulation as an adjunct to functional task practice training: a, randomized, comparative pilot study in people with cervical spinal cord injury. Clin. Rehabil. 29, 771–782.
53.
InaniciF., SamejimaS., GadP., EdgertonV.R., HofstetterC.P., and MoritzC.T. (2018). Transcutaneous electrical spinal stimulation promotes long-term recovery of upper extremity function in chronic tetraplegia. IEEE Trans. Neural Syst. Rehabil. Eng. 26, 1272–1278.
54.
WagnerF.B., MignardotJ.B., Le Goff-MignardotC.G., DemesmaekerR., KomiS., CapogrossoM., RowaldA., SeanezI., CabanM., PirondiniE., VatM., McCrackenL.A., HeimgartnerR., FodorI., WatrinA., SeguinP., PaolesE., Van Den KeybusK., EberleG., SchurchB., PralongE., BecceF., PriorJ., BuseN., BuschmanR., NeufeldE., KusterN., CardaS., von ZitzewitzJ., DelattreV., DenisonT., LambertH., MinassianK., BlochJ., and CourtineG. (2018). Targeted neurotechnology restores walking in humans with spinal cord injury. Nature, 563, 65–71.
55.
EstesS., IddingsJ.A., RayS., Kirk-SanchezN.J., and Field-FoteE.C. (2018). Comparison of single-session dose response effects of whole body vibration on spasticity and walking speed in persons with spinal cord injury. Neurotherapeutics, 15, 684–696.
56.
HofstoetterU.S., FreundlB., DannerS.M., KrennM.J., MayrW., BinderH., and MinassianK. (2020). Transcutaneous spinal cord stimulation induces temporary attenuation of spasticity in individuals with spinal cord injury. J. Neurotrauma, 37, 481–493.
57.
HofstoetterU.S., FreundlB., BinderH., and MinassianK. (2018). Common neural structures activated by epidural and transcutaneous lumbar spinal cord stimulation: elicitation of posterior root-muscle reflexes. PLoS One, 13, e0192013.
58.
HoferA.S., and SchwabM.E. (2019). Enhancing rehabilitation and functional recovery after brain and spinal cord trauma with electrical neuromodulation. Curr. Opin. Neurol. 32, 828–835.
59.
HansenC.N., FisherL.C., DeibertR.J., JakemanL.B., ZhangH., Noble-HaeussleinL., WhiteS., and BassoD.M. (2013). Elevated MMP-9 in the lumbar cord early after thoracic spinal cord injury impedes motor relearning in mice. J. Neurosci. 33, 13101–13111.
60.
BassoD.M., and LangC.E. (2017). Consideration of dose and timing when applying interventions after stroke and spinal cord injury. J. Neurol. Phys. Ther. 41, Suppl. 3, S24–S31.
61.
McGeeM.J., AmundsenC.L., and GrillW.M. (2015). Electrical stimulation for the treatment of lower urinary tract dysfunction after spinal cord injury. J.. Spinal Cord Med. 38, 135–146.
62.
GararaB., WoodA., MarcusH.J., TsangK., WilsonM.H., and KhanM. (2016). Intramuscular diaphragmatic stimulation for patients with traumatic high cervical injuries and ventilator dependent respiratory failure: a systematic review of safety and effectiveness. Injury, 47, 539–544.
63.
PoslusznyJ.A.Jr., OndersR., KerwinA.J., WeinsteinM.S., SteinD.M., KnightJ., LottenbergL., CheathamM.L., KhansariniaS., DayalS., ByersP.M., and DiebelL. (2014). Multicenter review of diaphragm pacing in spinal cord injury: successful not only in weaning from ventilators but also in bridging to independent respiration. J.. Trauma Acute Care Surg. 76, 303–309; discussion, 309–310.
64.
ShavelleR.M., DeVivoM.J., BrooksJ.C., StraussD.J., and PaculdoD.R. (2015). Improvements in long-term survival after spinal cord injury?. Arch. Phys. Med. Rehabil. 96, 645–651.
65.
KrauseJ.S., CaoY., DeVivoM.J., and DiPiroN.D. (2016). Risk and protective factors for cause-specific mortality after spinal cord injury. Arch. Phys. Med. Rehabil. 97, 1669–1678.
66.
CaoY., KrauseJ.S., and DiPiroN. (2013). Risk factors for mortality after spinal cord injury in the USA. Spinal Cord, 51, 413–418.
67.
National Spinal Cord Injury Statistical Center. (2019). Facts and Figures at a Glance. University of Alabama at Birmingham: Birmingham,AL.
68.
BammanM.M. (2008). Regulation of muscle size in humans: role of myostatin?. J. Musculoskelet. Neuronal Interact. 8, 342–343.
69.
BanerjeaR., SambamoorthiU., WeaverF., ManeyM., PogachL.M., and FindleyT. (2008). Risk of stroke, heart attack, and diabetes complications among veterans with spinal cord injury. Arch. Phys. Med. Rehabil. 89, 1448–1453.
70.
PetrieM.A., SharmaA., TaylorE.B., SunejaM., and ShieldsR.K. (2020). Impact of short- and long-term electrically induced muscle exercise on gene signaling pathways, gene expression, and PGC1a methylation in men with spinal cord injury. Physiol. Genomics, 52, 71–80.
71.
ShieldsR.K. (2017). Turning over the hourglass. Phys. Ther. 97, 949–963.
72.
DenhamJ. (2018). Exercise and epigenetic inheritance of disease risk. Acta Physiol. (Oxf.) 222. doi: 10.1111/apha.12881.
73.
IizukaK., MachidaT., and HirafujiM. (2014). Skeletal muscle is an endocrine organ. J. Pharmacol. Sci. 125, 125–131.
74.
PedersenB.K. (2013). Muscle as a secretory organ. Compr. Physiol. 3, 1337–1362.
75.
SchnyderS., and HandschinC. (2015). Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise. Bone, 80, 115–125.
76.
WrannC.D., WhiteJ.P., SalogiannnisJ., Laznik-BogoslavskiD., WuJ., MaD., LinJ.D., GreenbergM.E., and SpiegelmanB.M. (2013). Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell Metab. 18, 649–659.
77.
BattaglinoR.A., LazzariA.A., GarshickE., and MorseL.R. (2012). Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies. Curr. Osteoporos Rep. 10, 278–285.
78.
Dudley-JavoroskiS., and ShieldsR.K. (2008). Muscle and bone plasticity after spinal cord injury: review of adaptations to disuse and to electrical muscle stimulation. J. Rehabil. Res. Dev. 45, 283–296.
79.
Dudley-JavoroskiS., and ShieldsR.K. (2012). Regional cortical and trabecular bone loss after spinal cord injury. J. Rehabil. Res. Dev. 49, 1365–1376.
80.
EdwardsW.B., SchnitzerT.J., and TroyK.L. (2013). Bone mineral loss at the proximal femur in acute spinal cord injury. Osteoporos. Int. 24, 2461–2469.
81.
MaimounL., FattalC., and SultanC. (2011). Bone remodeling and calcium homeostasis in patients with spinal cord injury: a review. Metabolism, 60, 1655–1663.
82.
SzollarS.M., MartinE.M., SartorisD.J., ParthemoreJ.G., and DeftosL.J. (1998). Bone mineral density and indexes of bone metabolism in spinal cord injury. Am. J. Phys. Med. Rehabil. 77, 28–35.
83.
GroahS.L., NashM.S., WardE.A., LibinA., MendezA.J., BurnsP., ElrodM., and HammL.F. (2011). Cardiometabolic risk in community-dwelling persons with chronic spinal cord injury. J. Cardiopulm. Rehabil. Prev. 31, 73–80.
84.
LavelaS.L., WeaverF.M., GoldsteinB., ChenK., MiskevicsS., RajanS., and GaterD.R.Jr. (2006). Diabetes mellitus in individuals with spinal cord injury or disorder. J. Spinal Cord. Med. 29, 387–395.
85.
OkulI., UnalanH., ErhanB., DamciT., and UludagM. (2007). Glucose intolerance, insulin resistance, and C peptide levels in patients with spinal cord injury. Neurosurg. Quart. 17, 170–174.
86.
Martin GinisK.A., van der ScheerJ.W., Latimer-CheungA.E., BarrowA., BourneC., CarruthersP., BernardiM., DitorD.S., GaudetS., de GrootS., HayesK.C., HicksA.L., LeichtC.A., LexellJ., MacalusoS., MannsP.J., McBrideC.B., NoonanV.K., PomerleauP., RimmerJ.H., ShawR.B., SmithB., SmithK.M., SteevesJ.D., TusslerD., WestC.R., WolfeD.L., and Goosey-TolfreyV.L. (2018). Evidence-based scientific exercise guidelines for adults with spinal cord injury: an update and a new guideline. Spinal Cord, 56, 308–321.
87.
MoonH.Y., BeckeA., BerronD., BeckerB., SahN., BenoniG., JankeE., LubejkoS.T., GreigN.H., MattisonJ.A., DuzelE., and van PraagH. (2016). Running-induced systemic cathepsin b secretion is associated with memory function. Cell Metab. 24, 332–340.
88.
ZhorneR., Dudley-JavoroskiS., and ShieldsR.K. (2016). Skeletal muscle activity and CNS neuro-plasticity. Neural Regen. Res. 11, 69–70.
89.
KigerlK.A., ZaneK., AdamsK., SullivanM.B., and PopovichP.G. (2020). The spinal cord-gut-immune axis as a master regulator of health and neurological function after spinal cord injury. Exp. Neurol. 323, 113085.
90.
KigerlK.A., MostacadaK., and PopovichP.G. (2018). Gut microbiota are disease-modifying factors after traumatic spinal cord injury. Neurotherapeutics, 15, 60–67.
91.
O'ConnorG., JeffreyE., MadormaD., MarcilloA., AbreuM.T., DeoS.K., DietrichW.D., and DaunertS. (2018). Investigation of microbiota alterations and intestinal inflammation post-spinal cord injury in rat model. J. Neurotrauma, 35, 2159–2166.
92.
ZhangC., ZhangW., ZhangJ., JingY., YangM., DuL., GaoF., GongH., ChenL., LiJ., LiuH., QinC., JiaY., QiaoJ., WeiB., YuY., ZhouH., LiuZ., YangD., and LiJ. (2018). Gut microbiota dysbiosis in male patients with chronic traumatic complete spinal cord injury. J. Transl. Med. 16, 353.
93.
GungorB., AdiguzelE., GurselI., YilmazB., and GurselM. (2016). Intestinal microbiota in patients with spinal cord injury. PLoS One, 11, e0145878.
TicinesiA., LauretaniF., MilaniC., NouvenneA., TanaC., Del RioD., MaggioM., VenturaM., and MeschiT. (2017). Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?. Nutrients, 9, 1303.
96.
SauerbeckA.D., LawsJ.L., BandaruV.V., PopovichP.G., HaugheyN.J., and McTigueD.M. (2015). Spinal cord injury causes chronic liver pathology in rats. J. Neurotrauma, 32, 159–169.
97.
CraggsM., and McFarlaneJ. (1999). Neuromodulation of the lower urinary tract. Exp. Physiol. 84, 149–160.
98.
CardenasD.D., HoffmanJ.M., KirshblumS. and McKinleyW. (2004). Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch. Phys. Med. Rehabil. 85, 1757–1763.
99.
DeJongG., TianW., HsiehC.H., JunnC., KaramC., BallardP.H., SmoutR.J., HornS.D., ZancaJ.M., HeinemannA.W., HammondF.M., and BackusD. (2013). Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch. Phys. Med. Rehabil. 94, S87–S97.
100.
SkeltonF., SalemiJ.L., AkpatiL., SilvaS., DongarwarD., TrautnerB.W., and SalihuH.M. (2019). Genitourinary complications are a leading and expensive cause of emergency department and inpatient encounters for persons with spinal cord injury. Arch. Phys. Med. Rehabil. 100, 1614–1621.
101.
OngB., WilsonJ.R., and HenzelM.K. (2020). Management of the patient with chronic spinal cord injury. Med. Clin. North Am. 104, 263–278.
102.
GauntR.A., and ProchazkaA. (2006). Control of urinary bladder function with devices: successes and failures. Prog. Brain Res. 152, 163–194.
103.
WollnerJ., KrebsJ., and PannekJ. (2016). Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction. Spinal Cord, 54, 137–140.
104.
LombardiG., MuscoS., CelsoM., Del CorsoF., and Del PopoloG. (2014). Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord, 52, 241–245.
105.
AlmM., SarasteH., and NorrbrinkC. (2008). Shoulder pain in persons with thoracic spinal cord injury: prevalence and characteristics. J. Rehabil. Med. 40, 277–283.
106.
CurtisK.A., DrysdaleG.A., LanzaR.D., KolberM., VitoloR.S., and WestR. (1999). Shoulder pain in wheelchair users with tetraplegia and paraplegia. Arch. Phys. Med. Rehabil. 80, 453–457.
107.
DalyanM., CardenasD.D., and GerardB. (1999). Upper extremity pain after spinal cord injury. Spinal Cord, 37, 191–195.
108.
DivanoglouA., AugutisM., SveinssonT., HultlingC., and LeviR. (2018). Self-reported health problems and prioritized goals in community-dwelling individuals with spinal cord injury in Sweden. J. Rehabil. Med. 50, 872–878.
109.
Dyson-HudsonT.A., and KirshblumS.C. (2004). Shoulder pain in chronic spinal cord injury, part I: epidemiology, etiology, and pathomechanics. J. Spinal Cord Med. 27, 4–17.
110.
UllrichP.M., JensenM.P., LoeserJ.D., and CardenasD.D. (2008). Pain intensity, pain interference and characteristics of spinal cord injury. Spinal Cord, 46, 451–455.
111.
YangJ., BoningerM.L., LeathJ.D., FitzgeraldS.G., Dyson-HudsonT.A., and ChangM.W. (2009). Carpal tunnel syndrome in manual wheelchair users with spinal cord injury: a cross-sectional multicenter study. Am. J. Phys. Med. Rehabil. 88, 1007–1016.
112.
AkbarM., BaleanG., BrunnerM., SeylerT.M., BrucknerT., MunzingerJ., GrieserT., GernerH.J., and LoewM. (2010). Prevalence of rotator cuff tear in paraplegic patients compared with controls. J. Bone Joint Surg. Am. 92, 23–30.
113.
AkbarM., BrunnerM., BaleanG., GrieserT., BrucknerT., LoewM., and RaissP. (2011). A cross-sectional study of demographic and morphologic features of rotator cuff disease in paraplegic patients. J. Shoulder Elbow Surg. 20, 1108–1113.
114.
EscobedoE.M., HunterJ.C., HollisterM.C., PattenR.M., and GoldsteinB. (1997). MR imaging of rotator cuff tears in individuals with paraplegia. AJR Am. J. Roentgenol. 168, 919–923.
115.
PepkeW., BrunnerM., AbelR., AlmansourH., GernerH.J., HugA., ZeifangF., KentarY., BrucknerT., and AkbarM. (2018). [Risk factors for the development of rotator cuff tears in individuals with paraplegia: a cross-sectional study]. [Article in German]. Orthopade, 47, 561–566.
116.
Paralyzed Veterans of America Consortium for Spinal Cord Medicine. (2005). Preservation of upper limb function following spinal cord injury: a clinical practice guideline for health-care professionals. J. Spinal Cord Med. 28, 434–470.
117.
National Institutes of Health. (2020). All of Us Research Program. National Institutes of Health: Bethesda,MD.
118.
KoortsH., EakinE., EstabrooksP., TimperioA., SalmonJ., and BaumanA. (2018). Implementation and scale up of population physical activity interventions for clinical and community settings: the PRACTIS guide. Int. J. Behav. Nutr. Phys. Act. 15, 51.
119.
MunceS.E.P., GrahamI.D., SalbachN.M., JaglalS.B., RichardsC.L., EngJ.J., DesrosiersJ., MacKay-LyonsM., Wood-DauphineeS., Korner-BitenskyN., MayoN.E., TeasellR.W., ZwarensteinM., MokryJ., BlackS., and BayleyM.T. (2017). Perspectives of health care professionals on the facilitators and barriers to the implementation of a stroke rehabilitation guidelines cluster randomized controlled trial. BMC Health Serv. Res. 17, 440.
120.
CollingerJ.L., KrygerM.A., BarbaraR., BetlerT., BowsherK., BrownE.H., ClantonS.T., DegenhartA.D., FoldesS.T., GauntR.A., GyulaiF.E., HarchickE.A., HarringtonD., HelderJ.B., HemmesT., JohannesM.S., KatyalK.D., LingG.S., McMorlandA.J., PalkoK., ParaM.P., ScheuermannJ., SchwartzA.B., SkidmoreE.R., SolzbacherF., SrikameswaranA.V., SwansonD.P., SwetzS., Tyler-KabaraE.C., VellisteM., WangW., WeberD.J., WodlingerB., and BoningerM.L. (2014). Collaborative approach in the development of high-performance brain-computer interfaces for a neuroprosthetic arm: translation from animal models to human control. Clin. Transl. Sci. 7, 52–59.
121.
AjiboyeA.B., WillettF.R., YoungD.R., MembergW.D., MurphyB.A., MillerJ.P., WalterB.L., SweetJ.A., HoyenH.A., KeithM.W., PeckhamP.H., SimeralJ.D., DonoghueJ.P., HochbergL.R., and KirschR.F. (2017). Restoration of reaching and grasping movements through brain-controlled muscle stimulation in a person with tetraplegia: a proof-of-concept demonstration. Lancet, 389, 1821–1830.
122.
HeY., EgurenD., AzorinJ.M., GrossmanR.G., LuuT.P., and Contreras-VidalJ.L. (2018). Brain-machine interfaces for controlling lower-limb powered robotic systems. J. Neural Eng. 15, 021004.
123.
LuZ., StampasA., FranciscoG.E., and ZhouP. (2019). Offline and online myoelectric pattern recognition analysis and real-time control of a robotic hand after spinal cord injury. J. Neural Eng. 16, 036018.
124.
YooH.J., LeeS., KimJ., ParkC., and LeeB. (2019). Development of 3D-printed myoelectric hand orthosis for patients with spinal cord injury. J. Neuroeng. Rehabil. 16, 162.
125.
Contreras-VidalJ.L., KilicarslanA., HuangH., and GrossmanR.G. (2015). Human-centered design of wearable neuroprostheses and exoskeletons. AI Magazine, 36, 12–22.
126.
Contreras-VidalJ.L., N, A.B., BrantleyJ., Cruz-GarzaJ.G., HeY., ManleyQ., NakagomeS., NathanK., TanS.H., ZhuF., and PonsJ.L. (2016). Powered exoskeletons for bipedal locomotion after spinal cord injury. J. Neural Eng. 13, 031001.
127.
SpungenA.M., A.P., FinebergD., HarelN.Y., KornfeldS., and BaumanW.A (2015). Beneficial changes in body composition after exoskeletal-assisted walking: implications for improved metabolic function. Top. Spinal Cord Inj. Rehabil. 21, 110–121.
128.
TsaiC., AsselinP.K., KnezevicS., HarelN.Y., KornfeldS.D., and SpungenA.M. (2017). The effect of exoskeletal-assisted walking training on seated balance—a pilot study. 2017 International Symposium on Wearable Robotics and Rehabilitation (WeRob), Houston, TX, pps. 1–2.
129.
AsselinP., KnezevicS., KornfeldS., CirnigliaroC., Agranova-BreyterI., BaumanW.A., and SpungenA.M. (2015). Heart rate and oxygen demand of powered exoskeleton-assisted walking in persons with paraplegia. J. Rehabil. Res. Dev. 52, 147–158.
130.
EvansN., HartiganC., KandilakisC., PharoE., and ClessonI. (2015). Acute cardiorespiratory and metabolic responses during exoskeleton-assisted walking overground among persons with chronic spinal cord injury. Top. Spinal Cord Inj. Rehabil. 21, 122–132.
131.
LefeberN., SwinnenE., and KerckhofsE. (2017). The immediate effects of robot-assistance on energy consumption and cardiorespiratory load during walking compared to walking without robot-assistance: a systematic review. Disabil. Rehabil. Assist. Technol. 12, 657–671.
132.
GadP., GerasimenkoY., ZdunowskiS., TurnerA., SayenkoD., LuD.C., and EdgertonV.R. (2017). Weight bearing over-ground stepping in an exoskeleton with non-invasive spinal cord neuromodulation after motor complete paraplegia. Front. Neurosci. 11, 333.
133.
RamanujamA., HusainS.R., MomeniK., GarbariniE., AugustineJ., and ForrestG.F. (2017). Effects of longitudinal powered exoskeleton training on overground walking for SCI: a case study. 2017 International Symposium on Wearable Robotics and Rehabilitation (Werob), Houston, TX, pps. 19–20.
134.
BullardA.J., HutchisonB.C., LeeJ., ChestekC.A., and PatilP.G. (2020). Estimating risk for future intracranial, fully implanted, modular neuroprosthetic systems: a systematic review of hardware complications in clinical deep brain stimulation and experimental human intracortical arrays. Neuromodulation, 23, 411–426.
135.
BoutonC.E., ShaikhouniA., AnnettaN.V., BockbraderM.A., FriedenbergD.A., NielsonD.M., SharmaG., SederbergP.B., GlennB.C., MysiwW.J., MorganA.G., DeogaonkarM., and RezaiA.R. (2016). Restoring cortical control of functional movement in a human with quadriplegia. Nature, 533, 247–250.
136.
DowneyJ.E., BraneL., GauntR.A., Tyler-KabaraE.C., BoningerM.L., and CollingerJ.L. (2017). Motor cortical activity changes during neuroprosthetic-controlled object interaction. Sci. Rep. 7, 16947.
137.
MusienkoP., HeutschiJ., FriedliL., van den BrandR., and CourtineG. (2012). Multi-system neurorehabilitative strategies to restore motor functions following severe spinal cord injury. Exp. Neurol. 235, 100–109.
CourtineG., GerasimenkoY., van den BrandR., YewA., MusienkoP., ZhongH., SongB., AoY., IchiyamaR.M., LavrovI., RoyR.R., SofroniewM.V., and EdgertonV.R. (2009). Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat. Neurosci. 12, 1333–1342.
140.
EdgertonV.R., TillakaratneN.J., BigbeeA.J., de LeonR.D., and RoyR.R. (2004). Plasticity of the spinal neural circuitry after injury. Annu. Rev. Neurosci. 27, 145–167.
141.
AngeliC.A., BoakyeM., MortonR.A., VogtJ., BentonK., ChenY., FerreiraC.K., and HarkemaS.J. (2018). Recovery of over-ground walking after chronic motor complete spinal cord injury. N. Engl. J. Med. 379, 1244–1250.
142.
GillM.L., GrahnP.J., CalvertJ.S., LindeM.B., LavrovI.A., StrommenJ.A., BeckL.A., SayenkoD.G., Van StraatenM.G., DrubachD.I., VeithD.D., ThoresonA.R., LopezC., GerasimenkoY.P., EdgertonV.R., LeeK.H., and ZhaoK.D. (2018). Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia. Nat. Med. 24, 1677–1682.
143.
BonizzatoM., PidpruzhnykovaG., DiGiovannaJ., ShkorbatovaP., PavlovaN., MiceraS., and CourtineG. (2018). Brain-controlled modulation of spinal circuits improves recovery from spinal cord injury. Nat. Commun. 9, 3015.
144.
CapogrossoM., MilekovicT., BortonD., WagnerF., MoraudE.M., MignardotJ.B., BuseN., GandarJ., BarraudQ., XingD., ReyE., DuisS., JianzhongY., KoW.K., LiQ., DetempleP., DenisonT., MiceraS., BezardE., BlochJ., and CourtineG. (2016). A brain-spine interface alleviating gait deficits after spinal cord injury in primates. Nature, 539, 284–288.
145.
SavageN. (2018). The mind-reading devices that can free paralysed muscles. Nature, 555, S12–S15.
146.
HeY., EgurenD., LuuT.P., and Contreras-VidalJ.L. (2017). Risk management and regulations for lower limb medical exoskeletons: a review. Med. Devices (Auckl.) 10, 89–107.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
